Botanical species · safety record

Lycopus lucidus

The EFSA Compendium of Botanicals holds 2 adverse-effect records for Lycopus lucidus. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Lycopus lucidus Turcz. ex Benth.

0Constituent measurements
2Safety records
1Cited sources
15Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 15 licensed products naming Lycopus lucidus as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

  • Dry

Source material stated

  • Aerial parts
  • Herb
  • Herb top
  • Leaf
  • Whole plant(s)

What the records describe

Plant parts

  • Live plants2

Preparations

  • Solvent extraction2

Effect types

  • Digestive2

Target tissues

  • Digestive2

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

EffectTarget tissuePlant partPreparationTest organismTest typeSource
DigestiveDigestiveLive plantsSolvent extractionIn vitroResolve DOI
DigestiveDigestiveLive plantsSolvent extractionIn vitroResolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Yang, Bao-cheng., Peng, Tao., Zhang, Qianjun., Yin, Zhen-hua., Kang, Wenyi. alpha-Glucosidase Inhibitory Compounds of Lycopus lucidus var. hirtus. Chemistry of natural compounds, 2014, vol. 50, no. 1, p. 169-171. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue